Skip to main content

and
  1. Article

    Open Access

    Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial

    Association of immune-related adverse events with tumor response has been reported. Reactive cutaneous capillary endothelial proliferation (RCCEP) is the most common adverse event related to camrelizumab, an i...

    Feng Wang, Shukui Qin, **nchen Sun, Zhenggang Ren in Journal of Hematology & Oncology (2020)

  2. Article

    Open Access

    Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis

    Increased liver stiffness exerts a detrimental role in driving hepatocellular carcinoma (HCC) malignancy and progression, and indicates a high risk of unfavorable outcomes. However, it remains largely unknown ...

    Yinying Dong, Qiongdan Zheng, Zhiming Wang, **ahui Lin in Journal of Hematology & Oncology (2019)

  3. No Access

    Article

    Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study

    Patients with huge hepatocellular carcinoma >10 cm in diameter represent a special subgroup for treatment. To date, there are few data and little consensus on treatment strategies for huge hepatocellular carci...

    Tongchun Xue, Fan Le, Rongxin Chen, **aoying **e, Lan Zhang in Medical Oncology (2015)

  4. No Access

    Article

    Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection

    To explore the effect of lipiodolized transarterial chemoembolization (lip-TACE) in hepatocellular carcinoma (HCC) patients at different risk of recurrence after curative resection.

    **aohong Chen, Boheng Zhang, **n Yin in Journal of Cancer Research and Clinical On… (2013)